This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Croma Pharma Gmbh. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Heinrich Magometschnigg: Inventor in Venous Sclerotherapy.
Introduction
Heinrich Magometschnigg is an inventor associated with Salzburg, Austria, and Croma-Pharma GmbH. His patent work concerns sclerotherapy, a treatment approach for varicose, reticular, and spider veins.
Latest Patents
Magometschnigg is associated with 1 patent. The patent, titled “Sclerotherapy of Venous Blood Vessels,” describes a sclerosing agent formulated with a water-soluble cellulose derivative. It also covers a pharmaceutical composition containing these ingredients, a kit, and a method for producing a foam comprising the sclerosing agent and cellulose derivative.
Career Highlights
His patent focuses on the formulation and preparation of sclerosing agents for treating venous blood vessels. The disclosed approaches include combining the agent with a water-soluble cellulose derivative and producing a foam for use in treatment.
Collaborations
Magometschnigg is associated with Croma-Pharma GmbH. Michaela Magometschnigg is identified as his coworker.
Conclusion
Heinrich Magometschnigg’s recorded patent contribution centers on sclerotherapy formulations and foam preparation for treating varicose, reticular, and spider veins.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile